Cryoport (NASDAQ: CYRX) plans sale of 28,800 common shares

Cryoport, Inc. has filed a Form 144 disclosing a planned sale of up to 28,800 common shares on NASDAQ, with an aggregate value of $426,816.00. The shares, originating from restricted stock units and previously exercised holdings acquired on February 29, 2012, are intended to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. This filing indicates a neutral impact and sentiment according to Rhea-AI.